Reference

The effect of GLP-1 analogs and GSK-3β inhibitor drugs on Alzheimer's and Parkinson's diseases prognosis in diabetic patients.

https://chemistry-europe.onlinelibrary.wiley.com/doi/full/10.1002/cmdc.200500039https://doi.org/10.1016/j.diabet.2023.101470https://www.sciencedirect.com/science/article/abs/pii/S0166432817315292https://doi.org/10.1007/s12035-024-04003-zhttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0087095https://doi.org/10.1007/s10654-023-00970-0